Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older - Concepedia

Concepedia

Publication | Open Access

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older

DOI Full Paper Access

78

Citations

28

References

2016

Year

Héctor S. Izurieta, Michael Wernecke, Jeffrey A. Kelman, Sarah Anne Wong, Richard A. Forshee, Douglas Pratt, Yun Lu, Qin Sun, Christopher Jankosky, Philip R. Krause,

Clinical Infectious Diseases

Abstract

In both the primary and secondary analyses, HZV provided protection against HZ across all ages, but effectiveness declined over time. VE was higher and better preserved over time for PHN and HZ-associated hospitalizations than for community HZ.

References

	Year	Citations

Page 1